The same correlation was recently observed in GISTs by Zhao et al. [46], who confirmed that PD-L1 mRNA expression is a factor of unfavorable outcome associated with therapy-resistant, high-risk GIST patients. The gene discussed is CD274; the disease is gastrointestinal stromal tumor.